The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
The company has also launched Elyara, a portfolio of products in regenerative medical aesthetics focused on non-invasive skin and hair restoration
Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures
The medtech firm strengthens its full-stack remote cardiac monitoring platform, achieves 11x revenue growth, and advances its global expansion plans
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Muted movement reflects consolidation phase as investors await earnings triggers
The investment case for health technology in India is frequently overstated in one direction and understated in another
AI-enabled women’s digital clinic brings in-person consultations to complement app-led care after serving over 400,000 women across India
Subscribe To Our Newsletter & Stay Updated
